Literature DB >> 27297397

Detergent Isolation Stabilizes and Activates the Shigella Type III Secretion System Translocator Protein IpaC.

Abram R Bernard1, Shari M Duarte1, Prashant Kumar2, Nicholas E Dickenson3.   

Abstract

Shigella rely on a type III secretion system as the primary virulence factor for invasion and colonization of human hosts. Although there are an estimated 90 million Shigella infections, annually responsible for more than 100,000 deaths worldwide, challenges isolating and stabilizing many type III secretion system proteins have prevented a full understanding of the Shigella invasion mechanism and additionally slowed progress toward a much needed Shigella vaccine. Here, we show that the non-denaturing zwitterionic detergent N, N-dimethyldodecylamine N-oxide (LDAO) and non-ionic detergent n-octyl-oligo-oxyethylene efficiently isolated the hydrophobic Shigella translocator protein IpaC from the co-purified IpaC/IpgC chaperone-bound complex. Both detergents resulted in monomeric IpaC that exhibits strong membrane binding and lysis characteristics while the chaperone-bound complex does not, suggesting that the stabilizing detergents provide a means of following IpaC "activation" in vitro. Additionally, biophysical characterization found that LDAO provides significant thermal and temporal stability to IpaC, protecting it for several days at room temperature and brief exposure to temperatures reaching 90°C. In summary, this work identified and characterized conditions that provide stable, membrane active IpaC, providing insight into key interactions with membranes and laying a strong foundation for future vaccine formulation studies taking advantage of the native immunogenicity of IpaC and the stability provided by LDAO.
Copyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  circular dichroism; light scattering (dynamic); liposomes; physical characterization; physical stability

Mesh:

Substances:

Year:  2016        PMID: 27297397      PMCID: PMC4921279          DOI: 10.1016/j.xphs.2016.05.015

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  50 in total

Review 1.  Invasion of epithelial cells by bacterial pathogens the paradigm of Shigella.

Authors:  K Niebuhr; P J Sansonetti
Journal:  Subcell Biochem       Date:  2000

2.  Structure and composition of the Shigella flexneri "needle complex", a part of its type III secreton.

Authors:  A Blocker; N Jouihri; E Larquet; P Gounon; F Ebel; C Parsot; P Sansonetti; A Allaoui
Journal:  Mol Microbiol       Date:  2001-02       Impact factor: 3.501

3.  Newly emerged multiple-antibiotic-resistant Shigella dysenteriae type 1 strains in and around Kolkata, India, are clonal.

Authors:  Shanta Dutta; Ayantika Ghosh; Kaushik Ghosh; Dharitri Dutta; Sujit K Bhattacharya; G Balakrish Nair; Shin-ichi Yoshida
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

Review 4.  The type III secretion system tip complex and translocon.

Authors:  C A Mueller; P Broz; G R Cornelis
Journal:  Mol Microbiol       Date:  2008-04-08       Impact factor: 3.501

5.  Identification of the bile salt binding site on IpaD from Shigella flexneri and the influence of ligand binding on IpaD structure.

Authors:  Michael L Barta; Manita Guragain; Philip Adam; Nicholas E Dickenson; Mrinalini Patil; Brian V Geisbrecht; Wendy L Picking; William D Picking
Journal:  Proteins       Date:  2012-03

6.  The development of a FACS-based strategy for the isolation of Shigella flexneri mutants that are deficient in intercellular spread.

Authors:  M Rathman; N Jouirhi; A Allaoui; P Sansonetti; C Parsot; G Tran Van Nhieu
Journal:  Mol Microbiol       Date:  2000-03       Impact factor: 3.501

7.  Structure-function analysis of invasion plasmid antigen C (IpaC) from Shigella flexneri.

Authors:  Lisa A Kueltzo; John Osiecki; Jeff Barker; Wendy L Picking; Baran Ersoy; William D Picking; C Russell Middaugh
Journal:  J Biol Chem       Date:  2002-11-08       Impact factor: 5.157

8.  Combination of two separate binding domains defines stoichiometry between type III secretion system chaperone IpgC and translocator protein IpaB.

Authors:  Ravi Kumar Lokareddy; Michele Lunelli; Björn Eilers; Vivien Wolter; Michael Kolbe
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

9.  Deoxycholate interacts with IpaD of Shigella flexneri in inducing the recruitment of IpaB to the type III secretion apparatus needle tip.

Authors:  Kenneth F Stensrud; Philip R Adam; Cassandra D La Mar; Andrew J Olive; Gerald H Lushington; Raghavi Sudharsan; Naomi L Shelton; Richard S Givens; Wendy L Picking; William D Picking
Journal:  J Biol Chem       Date:  2008-05-01       Impact factor: 5.157

10.  The tripartite type III secreton of Shigella flexneri inserts IpaB and IpaC into host membranes.

Authors:  A Blocker; P Gounon; E Larquet; K Niebuhr; V Cabiaux; C Parsot; P Sansonetti
Journal:  J Cell Biol       Date:  1999-11-01       Impact factor: 10.539

View more
  3 in total

Review 1.  The Shigella Type III Secretion System: An Overview from Top to Bottom.

Authors:  Meenakumari Muthuramalingam; Sean K Whittier; Wendy L Picking; William D Picking
Journal:  Microorganisms       Date:  2021-02-22

2.  Addition of Lauryldimethylamine N-Oxide (LDAO) to a Copper-Free Click Chemistry Reaction Improves the Conjugation Efficiency of a Cell-Free Generated CRM197 Variant to Clinically Important Streptococcus pneumoniae Serotypes.

Authors:  Leslie Bautista; Lucy Pill-Pepe; Neeraj Kapoor; Scott Snyder; Ellen Chu; Paresh Agarwal; Mohammed Sardar; Shylaja Arulkumar; Aym Berges; Mark Iverson; Christopher Behrens; Olivier Marcq; Jeff Fairman
Journal:  ACS Omega       Date:  2022-09-20

3.  Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex.

Authors:  K Ross Turbyfill; Kristen A Clarkson; Anthony R Vortherms; Edwin V Oaks; Robert W Kaminski
Journal:  mSphere       Date:  2018-03-28       Impact factor: 4.389

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.